An observational study in Vascular Access Complication and Apheresis Related Complication, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-24.
Sponsored by Central Hospital, Nancy, France · Observational
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
Complications may include arterio-veinous fistula or graft (AVF or AVG) thrombosis with or without known stenosis; AVF or AVG or central veinous catheter (CVC) infections and CVC dysfunctions.
The investigators may enroll all patients receveing therapeutic apheresis for nephrologic indications in North East France.
Nephrologics indications include :
Data inclusion period is from June 2020 to June 2022.
The aim of the study is to describe the proportion and type of complication in the population of patient receving therapeutic apheresis for nephrologic disease in the North East France. Te investigators will study the risk factors that are associated with this complications.
The second aim of the study is to describe the population of patient receving therapeutic apheresis in our unit and in our region.
Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients in nephrology receiveing apheresis treatment by filtration or double filtration with arterioveinous fistula or arterioveinous graft or central veinous catheter
Exclusion Criteria:
Vascular access Complication (catheter or AVF/AVG thrombosis/infection) rate in therapeutic apheresis among nephrological diseases
Percent of patient with Vascular access Complication
Time frame: june 2020 june 2022
Description of population enrolled
Description of population treated by therapeutic apheresis in Northeast France
Time frame: june 2020 june 2022
Comparison of complications rate with literature datas
Time frame: june 2020 june 2022
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France